This trial is evaluating whether SAM Clinic Intervention will improve 2 primary outcomes, 5 secondary outcomes, and 1 other outcome in patients with Apnea. Measurement will happen over the course of Baseline to 3 month follow up.
This trial requires 166 total participants across 2 different treatment groups
This trial involves 2 different treatments. SAM Clinic Intervention is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
About 1.7 million Americans have a complaint of snoring or apnea each year. apnoea occurs approximately 30 million times a year in the U.S., making it an important aspect of health.
Apnea is caused by abnormalities in the central pattern generator that results in a failure in voluntary respiratory drive. Hypoxia is an important stimulus that stimulates respiratory apnea. Dysfunction of central patterns, respiratory drive and central control of respiration, particularly in the control of ventilation in response to hypoxia, are implicated in apnea of prematurity, and may contribute to its pathogenesis.
Changes in breathing during sleep, and sleep apnea, may be noticeable from the signs of excessive daytime sleepiness, irritability, lethargy, and poor concentration that many patients with sleep apnea experience. As more sufferers of sleep apnea go unrecognized, the health care profession will experience the most damage to the patient and to society when this unrecognized health problem begins. More studies of sleep apnea in a wide variety of sleep centers and in the community-wide population are needed.
Even after adjusting for age, gender, and marital status, the risk for [sleep apnea](https://www.withpower.com/clinical-trials/sleep-apnea) is increased in children of African Americans. The risk for obstructive sleep apnea is related to the severity of obesity. In a recent study, findings may be explained by a stronger association of obesity with the onset of sleep abnormalities in African Americans.
There is a significant benefit in not using positive airway pressure, but a risk of worsening hypoxia or pulmonary hypertension. There is a similar benefit in eliminating sleep apnea without using positive airway pressure. Some patients do well with nasal Continuous Positive Airway Pressure alone.
Most studies reviewed in this paper focus on specific agents and therapies that are commonly prescribed by adult patients for the treatment of apnea. Examples include (1) medications to treat or prevent asthma, (2) medications that have been approved by the FDA for use in treating obstructive [sleep apnea](https://www.withpower.com/clinical-trials/sleep-apnea), (3) medications used to stabilize heart rhythm disturbances during sleep. None of the studies reviewed describes a common medications used by patients to treat and/or prevent apnea in infants. It is imperative for caregivers to be aware of the most commonly used medications to treat apnea in infants.
It is difficult to know all the research for a condition, because the research is in the form of [randomized controlled trials], which take a long time to complete. In order to keep up to date, please take a look at the [APNA-CATEGORIES] (APNA = Apnea – Category) by [www.apnacategories.com]. You can find reviews for every category for recent events and clinical trials.
[Approximately 3% of normal adults experience apnea annually, with rates of asymptomatic cases rising to 40% in patients > 60 years old (3)(4). While the diagnosis and treatment of apnea are often challenging and are best managed by a professional with the appropriate knowledge and training, the complications it can cause, particularly if untreated, are quite serious. In addition to having to decide whether to treat apnea, patients will have to deal with the consequences of untreated apnea, including problems with concentration and sleepiness. In the event of complications, apnea can contribute to morbidity and mortality, requiring urgent intervention to ensure that breathing and circulation are maintained safely.
If you are a health care provider and you're being asked to make a diagnosis in the ED, you should expect to be asked about apnea, and therefore have a basic understanding of what is normal and abnormal, as well as the average age that is diagnosed.\n
It was concluded that the use of a sam clinic for [smoking cessation](https://www.withpower.com/clinical-trials/smoking-cessation) was more effective than a placebo for the cessation of smoking behavior. The sam clinic was particularly effective in smokers who were older and who had low motivation.
Recent findings of these 2 retrospective analyses support that patients who present with persistent abnormal respiratory events after surgery or with postoperative apnea may find them helpful when considering clinical trials.